Bellevue Group Ag Johnson & Johnson Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Johnson & Johnson stock. As of the latest transaction made, Bellevue Group Ag holds 51,242 shares of JNJ stock, worth $7.4 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

51,242

Previous 7,797 557.2%

Holding current value

$7.4 Million

Previous $1.14 Million 629.06%

% of portfolio

0.14%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $6.32 Million - $7.27 Million	43,445 Added 557.2%	51,242 $8.3 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $198,811 - $217,263	1,377 Added 21.45%	7,797 $1.14 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $3.39 Million - $3.56 Million	-21,860 Reduced 77.3%	6,420 $1.02 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $794,539 - $867,008	5,457 Added 23.91%	28,280 $4.43 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $248,888 - $278,819	1,598 Added 7.53%	22,823 $3.55 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $259,308 - $279,064	-1,680 Reduced 7.33%	21,225 $3.51 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $471,578 - $562,771	-3,122 Reduced 12.0%	22,905 $3.55 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $743,968 - $834,944	-4,644 Reduced 15.14%	26,027 $4.6 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $283,456 - $315,416	1,757 Added 6.08%	30,671 $5.01 Million
Q2 2022 Aug 11, 2022	BUY	$168.19 - $186.01 $204,182 - $225,816	1,214 Added 4.38%	28,914 $5.13 Million
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $1.19 Million - $1.35 Million	7,500 Added 37.13%	27,700 $4.91 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $1.61 Million - $1.78 Million	-10,300 Reduced 33.77%	20,200 $3.46 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $80,750 - $89,735	-500 Reduced 1.61%	30,500 $4.93 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $1.61 Million - $1.73 Million	-10,100 Reduced 24.57%	31,000 $5.11 Million
Q1 2021 May 12, 2021	BUY	$153.07 - $170.48 $2.01 Million - $2.23 Million	13,100 Added 46.79%	41,100 $6.76 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $3.84 Million - $4.41 Million	28,000 New	28,000 $4.41 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $1.28 Million - $1.46 Million	-10,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $1.27 Million - $1.42 Million	10,000 New	10,000 $1.29 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $2.62 Million - $2.88 Million	-20,000 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$125.1 - $148.14 $750,600 - $888,839	-6,000 Reduced 23.08%	20,000 $2.56 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $721,710 - $789,910	-5,500 Reduced 17.46%	26,000 $3.63 Million
Q2 2017 Aug 14, 2017	BUY	N/A	31,500	31,500 $4.17 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Johnson & Johnson Transaction History